Exploring GLP-1 Medications and Pharma's Political Landscape

This chapter examines the emerging research on GLP-1 medications as potential treatments for addiction, highlighting the connection between these drugs and reduced cravings. It also discusses the political ramifications of Robert F. Kennedy Jr.'s criticisms of the pharmaceutical industry, exploring how his nomination for HHS secretary could impact pharma's operations. Additionally, the chapter reflects on the evolving relationship between major pharmaceutical companies and government administrations regarding drug pricing and regulation.